POSTPONED: The 3rd SCI-RSC Symposium on Transporters in Drug Discovery and Development

21 April 2020 00:00 - 22 April 2020 00:00, London , United Kingdom


Introduction
Cell surface transporters play a key role in human health and disease, both through their impact on drug disposition and as therapeutic targets in their own right. This third meeting in the series will feature talks on transporter structural biology, the impact of transporters on ADME and biodistribution, transporters as therapeutic targets and other aspects of transporters relevant to drug discovery and development.

Organised by SCI’s Fine Chemicals group, RSC’s Biological & Medicinal Chemistry Sector & the Drug Metabolism Discussion Group (DMDG)

​Programme
  • Genomics of transporters – informing drug development Kathleen Giacomini, SF, USA
  • MCT1 Graham Belfield, AstraZeneca, Switzerland
  • Malarial transporters Jeremy Burrows, Medicines for Malaria Venture, Switzerland
  • PBPK of transporter-mediated hepatic disposition using the imaging biomarker gadoxetate Daniel Scotcher, University of Manchester, UK
  • Transporter Structural Biology Kaspar Locher, ETH Zurich, Switzerland
  • Strategies for the pharmacological modulation of ABC transporters Christopher Koth, Genentech, USA
  • The evolution of transporters in drug discovery Anna-Lena Ungell, UCB, UK
  • New model for P-gp and CNS at the blood-brain barrie Holger Fischer, Roche, Switzerland
  • Transporter PBPK modeling and DDI Venkatesh Reddy, AstraZeneca, UK
Speakers
Venue
Society Of Chemical Industry

Auditorium, Society Of Chemical Industry, 14/15 Belgrave Square, London , SW1X 8PS, United Kingdom

Organised by
Organised by SCI’s Fine Chemicals group, RSC’s Biological & Medicinal Chemistry Sector & the Drug Metabolism Discussion Group (DMDG)
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*